Please login to the form below

Not currently logged in
Email:
Password:

Publicis boosts South Africa presence

Agency acquires local creative agency OwenKessel
South Africa flag

Publicis Groupe has announced its acquisition of South African creative agency OwenKessel.

Founded in 2008 by Felix Kessel and Vaughan Owen, OwenKessel is based in Johannesburg, with offices in Capetown.

The agency has 80 staff and works with blue-chip clients such as Aspen Pharmacare, Tanqueray Gin and TOTAL. A full-service agency, its offering includes consulting, creative, online marketing, social media and branded content.

OwenKessel is considered one of South Africa's top agencies, and has been a finalist at the South African 'Agency of the year' awards.

"South Africa is a key market with a large potential for growth. We have embarked on a very exciting journey here to bring the best capabilities and talents to our clients,” said Publicis Worldwide CEO Arthur Sadoun.

“With OwenKessel, we are adding great creative firepower that will ultimately benefit our local and international clients."

The newly acquired agency will be merged with the multi-door Publicis Groupe Africa network. CEO Felix Kessel will continue his current role in the new entity, reporting to Kevin Tromp, CEO of Sub-Saharan Africa for Publicis Worldwide.

Kessel said: "It's not often that you find two groups of people who actually share the same vision and objectives. The opportunity to drive this new agency to new creative heights is incredibly exciting to all of us.

“We are also looking forward to becoming part of Publicis Worldwide and playing a significant role beyond South Africa."

This is just the latest in a string of South African acquisitions for Publicis. The group has bought Synergize, AML and Lighthouse Digital over the past several months.

Article by
Tara Craig

11th April 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics